Evidence map›Paper›PMID 35484309›Full record

Trial reportScientific reports2022

A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products.

David Azzopardi, James Ebajemito, Michael McEwan, Oscar M Camacho, Jesse Thissen, George Hardie, Richard Voisine, Gavin Mullard, Zvi Cohen, James Murphy

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Oral nicotine pouches have arrived at U.S. college campuses.Journal of American college health : J of ACH · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

David AzzopardiBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK. David_Azzopardi@bat.com.
James EbajemitoBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.
Michael McEwanBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.
Oscar M CamachoBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.
Jesse ThissenBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.
George HardieBAT (Investments) Ltd, Research and Development, Regents Park Road, Southampton, SO15 8TL, UK.
Richard VoisineImperial Tobacco Canada, 3711 Saint-Antoine Street West, Montreal, QC, H4C 3P6, Canada.
Gavin MullardBAT (Holdings) Ltd, Globe House, 4 Temple Place, London, WC2R 2PG, UK.
Zvi CohenImperial Tobacco Canada, 3711 Saint-Antoine Street West, Montreal, QC, H4C 3P6, Canada.
James MurphyR.J. Reynolds Tobacco Company, 950 Reynolds Blvd, Winston-Salem, NC, 27105, USA.
British American Tobacco (United Kingdom) · GBBritish American Tobacco (Canada) · CAReynolds American (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine replacement therapies (NRTs) are intended for short-term use to help cigarette smokers to quit. Some smokers find NRTs ineffective or seek a more satisfactory source of nicotine. Tobacco-free oral nicotine pouch (NP) products have emerged as a potential reduced risk product compared with cigarettes and other tobacco products. In a randomised crossover clinical study, thirty-four healthy adult smokers were enrolled and their nicotine C

Indexed as

AlcoholismSmoking CessationTobacco ProductsBiological AvailabilityHumansNicotineTabletsTobacco Use Cessation DevicesNicotineTablets

Identifiers

PMID35484309
PMCPMC9050656
OpenAlexW4225004596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.